Business Wire

ADTRAN and Deutsche Telekom Look to Ultra Broadband Evolution to Advance the Gigabit Society

18.7.2017 09:00 | Business Wire

Del

ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation open networking solutions, today announced the start of lab testing of the latest innovations in the G.fast standard, 212MHz and coordinated dynamic time allocation (cDTA) together with Deutsche Telekom (DT). DT is evaluating these ultra-broadband technologies using Fibre-to-the-Building (FTTB) deployment models allowing the use of existing cable infrastructure within the home. This will allow the rapid deployment of ultra-fast and gigabit broadband services with minimal disruption. The low cost per subscriber connection pays directly into achieving European Commission’s Gigabit Society goals.

ADTRAN demonstrated the new 212MHz G.fast standard, which doubles the usable spectrum. This doubling of the usable spectrum allows service providers to deliver gigabit rates over a single copper pair, enabling robust fibre-like service delivery all the way to the customer premise. In contrast to cable systems, the bandwidth of G.fast is dedicated and available for each customer. The tests, leveraging the first commercially available 212MHz DPU also demonstrated the second phase of DTA. cDTA, like the earlier iDTA feature, improves G.fast upstream performance by four to five times by dynamically balancing upstream and downstream capacity to match residential traffic patterns in real-time. cDTA also expands the applicability of this feature to existing phone wiring, thus covering nearly all residential and commercial premises.

“Operators in highly competitive, dense urban or urban environments are challenged to extend gigabit services due to the time and cost that can be associated with pure play FTTH techniques,” said Jay Wilson, senior vice president at ADTRAN. “With G.fast innovation, operators, such as DT, can significantly accelerate Gigabit Society goals by launching gigabit services over their existing infrastructure dramatically reducing subscriber disruption.”

These two most recent G.fast advancements, 212MHz and cDTA, extract even greater overall performance from an operator’s existing assets, and in many scenarios, eliminates the need for full FTTH for years. For the first time, these G.fast innovations enable service providers to more rapidly and cost-effectively extend symmetric gigabit services and expand ultra-fast broadband to the wider market.

About ADTRAN

ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRAN’s products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are currently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit www.adtran.com.

About DT

Deutsche Telekom is one of the world's leading integrated telecommunications companies, with some 165 million mobile customers, 28,5 million fixed-network lines, and 18,5 million broadband lines. Deutsche Telekom provides fixed-network/broadband, mobile communications, Internet, and IPTV products and services for consumers, and information and communication technology (ICT) solutions for business and corporate customers. More information are available on https://www.telekom.com/en.

Contact information

Cohesive for ADTRAN
Kate Anderson, +44 (0) 1291 626200
adtran@wearecohesive.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 18:33Pressemelding

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 12:09Pressemelding

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 11:26Pressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 07:00Pressemelding

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 05:00Pressemelding

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom